Pharmalot… Pharmalittle… Good Morning
Make a commentBy Ed Silverman // July 21st, 2010 // 9:23 am
Hello, everyone. Sincere apologies for the delayed start, but we were experiencing those ubiquitous technical difficulties that can stop you dead in your tracks. Nonetheless, we are soldiering on. And so here are a few tidbits that you may have missed. Meanwhile, we are reaching for yet another cup of stimulation to compensate for the disturbances. Hope your day goes well…
Merck Buys Vaccine Unit From Hawaii Biotech (Honolulu Star-Advertiser)
Glaxo Takes New AIDS Drug To Final Test Stage (Reuters)
Lilly Closes $180M Deal For Alnara Pharmaceuticals (Associated Press)
Teva Agrees To End IP Suit Over Aricept Patent (Law360)
FDA Accepts MannKind Resubmission For Affrezza (PharmaTimes)
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
Affrezza, AIDS, Alnara Pharmaceuticals, Aricept, Dengue Fever, Eli Lilly, GlaxoSmithKline, Hawaii Biotech, MannKind, Merck, Patents, Shionogi, Teva Pharmaceuticals, Vaccines